Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation

OBJECTIVE: To define the pharmacokinetic (PK) parameters of 17-hydroxyprogesterone caproate (17-OHPC) in multifetal gestation. STUDY DESIGN: Blood was obtained at 24–28 weeks and at 32–35 weeks in 97 women with twin and 26 women with triplet gestation receiving 17-OHPC. Six of the women with twins h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Caritis, Steve N., Sharma, Shringi, Venkataramanan, Raman, Rouse, Dwight J., Peaceman, Alan M., Sciscione, Anthony, Spong, Catherine Y., Varner, Michael W., Malone, Fergal D., Iams, Jay D., Mercer, Brian M., Thorp, John M, Sorokin, Yoram, Carpenter, Marshall, Lo, Julie, Ramin, Susan, Harper, Margaret
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165062/
https://ncbi.nlm.nih.gov/pubmed/21620357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.03.028
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares